Le Cancer.fr

Purpose of the application
The “Le Cancer.fr” application is published by Cancérodigest SAS, an independent publishing company specializing in the writing, editing and dissemination of medical data and information for health professionals in the field of oncology and oncohematology. It provides these professionals with scientific information free of charge via secure access in oncology/cancerology, particularly in Digestive, Breast and Gynecological, Thoracic, Dermatological, Urological, Hematological tumors as well as in the fields of Immunology, Radiotherapy and Supportive Care.

Target audience of lecancer.fr
As part of the content of this application is intended for healthcare professionals, a verification of the RPPS number is carried out with the CNOM each time an account is created to allow them to consult the content.
Part of the content of this application contains oncology information accessible without restriction. Although this content has been created solely by professionals (doctors or paramedical professions) specialized in the field of oncology, it goes without saying that reading the information contained on our pages cannot in any way replace a consultation with your doctor. . Lecancer.fr cannot under any circumstances be held responsible for any erroneous or non-compliant interpretation of this information. Medical data and knowledge are constantly evolving and as a result the content of this site may change regularly, we therefore invite you to consult it regularly.

Responsibility
1. Medical information
Lecancer.fr respects the communication criteria concerning medical information. The site complies with the charter concluded between the ANSM (National Agency for the Safety of Medicines and Health Products) and the SNIP (National Union of the Pharmaceutical Industry) on December 26, 2000.

In accordance with the ANSM charter, published scientific information and in particular that linked to research or clinical study work, which is not in compliance with the French Marketing Authorization for pharmaceutical specialties must be read and understood with the greatest discernment and are given as part of their dissemination to the international scientific community.

Furthermore, Cancérodigest cannot under any circumstances be held responsible for any erroneous or non-compliant interpretation of the information contained on this site. Medical data and knowledge are constantly evolving and therefore the content of this site may change regularly. The content of the archives of this site may also therefore be or become obsolete. Cancérodigest invites the reader to refer to the publication dates of the data presented.

The information provided on this site is intended to improve, not replace, the relationship that exists between the patient (or site visitor) and his doctor.

2. Case of Congress reports:
Congress coverage is represented by reports and/or summaries of conference communications whose objective is to provide information on the current state of research; therefore, the data presented may not be validated by the French Authorities and, where applicable, should therefore not be put into practice.

3. Exclusion of certain damages
You use the lecancer.fr site at your own risk. If you are dissatisfied with any Content or with these terms and conditions, your only recourse is to discontinue use of the Site. For complete information, please consult our general conditions of use here: https://lecancer.fr/conditions-generales-dusage/